Many expensive new drugs are expected to hit the shelves in 2016, a year in which lawmakers are ramping up attention on the steep cost of treatments for some major diseases. Read More
Forecasting drug sales is a tricky business; just ask any biopharma CEO who has overpromised and underdelivered. The people who make it their business know that very well, and they update their numbers with every big shift in the market and every surprise result from a key clinical trial.
PSG offers the “In the Know” alert to keep you informed as new medications hit the market. Please click the link below to subscribe today. Subscribe